Thomas Malley - 18 Mar 2026 Form 4 Insider Report for Kura Oncology, Inc. (KURA)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
20 Mar 2026, 09:00:03 UTC
Prior SEC filing
14 Aug 2025
Next SEC filing
02 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Teresa Bair, Attorney-in-fact for Thomas Malley

Key filing fact

Thomas Malley filed Form 4 for Kura Oncology, Inc. (KURA) on 20 Mar 2026.

Key facts

  • This page summarizes Thomas Malley's Form 4 filing for Kura Oncology, Inc. (KURA).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 20 Mar 2026, 09:00.

Change

  • Previous filing in this sequence was filed on 14 Aug 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001403322 Primary reporting owner

Malley Thomas

Relationship
Director
Address
C/O KURA ONCOLOGY, INC., 4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO
Signature
/s/ Teresa Bair, Attorney-in-fact for Thomas Malley
Signature date
19 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

KURA transaction

Common Stock

Options Exercise

Transaction value
Shares
+10,000
Change %
Price
$3.12*
Shares after
10,000
Date
18 Mar 2026
Ownership
Direct
Footnotes
F1
KURA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
139,557
Date
18 Mar 2026
Ownership
By Mossrock Capital, LLC
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

KURA transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares
+10,000
Change %
Price
$0.000000*
Shares after
0
Date
18 Mar 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
10,000
Exercise price
$3.12
Footnotes
F1, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents stock options exercised.

Footnote F2

Mr. Malley serves as President of Mossrock Capital, LLC and has sole voting and investment power over these shares.

Footnote F3

This option is fully vested.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .